In a market where wellness has evolved from a consumer trend, BIO-YGEIA appears to be entering a more mature growth phase, capitalizing on the demand for nutrition and wellness products without sacrificing its profitability.
The company closed the previous fiscal year with revenue of €22.26 million, up 18.5%, while net profit after taxes stood at €1.67 million, recording an increase of over 25%. Gross profit amounted to €7.24 million and operating profit (EBIT) to €2.35 million.
The improvement in operating performance was also reflected in the balance sheet. Cash and cash equivalents nearly doubled, reaching €2.35 million from €1.26 million a year earlier, while long-term debt was reduced to €803,000 from €1.32 million.
At the same time, equity strengthened to €5.47 million from €4.40 million, allowing the company to distribute a dividend of €600,000 during the fiscal year. However, inventories remain at relatively high levels, at €2.77 million.
Since 2022, BIO-YGEIA has been controlled by Chain for Bios, the investment vehicle of the Tamvakakis family and Chrysostomos Mavropoulos, known for the Freskoulis brand, following the acquisition of 80% of the company a few years ago.